High Doses Of Common Chemo Drug Methotrexate Limit Relapses Of Childhood Leukemia

With a cure rate approaching 90 percent, acute lymphoblastic leukemia (ALL), the most common type of childhood cancer, is one of the big "success stories" of modern cancer treatment. Yet up to 20 percent of patients with a high risk of relapse are not cured, which could change with the results from a clinical trial showing that high doses of the commonly-used chemotherapy drug methotrexate increases the survival rate for these patients.

Read more here: http://www.science20.com/news_articles/high_doses_of_common_chemo_drug_methotrexate_limit_relapses_of_childhood_leukemia-171261